APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nausea Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nausea Medicine Industry Growth and Trends Forecast to 2032

20 December 202591 pages

Choose your research edition.

Industry ResearchNausea Medicine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Nausea Medicine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Nausea Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nausea Medicine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nausea Medicine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nausea Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nausea Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nausea Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nausea Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nausea Medicine include Sanofi, Merck, Roche, Pfizer, GlaxoSmithKline, TESARO and ANI Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nausea Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nausea Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nausea Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nausea Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nausea Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nausea Medicine Market by Company

Sanofi

Merck

Roche

Pfizer

GlaxoSmithKline

TESARO

ANI Pharmaceuticals

Nausea Medicine Segment by Type

Antagonists

Antacids

Steroids

Others

Nausea Medicine Segment by Application

Pharmaceutical Companies

Clinics

Hospital

Nausea Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nausea Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nausea Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nausea Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nausea Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nausea Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antagonists Table 2. Major Company of Antacids Table 3. Major Company of Steroids Table 4. Major Company of Others Table 5. Global Nausea Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 7. Global Nausea Medicine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Nausea Medicine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Nausea Medicine Sales Market Share in Value by Type (2021-2026) Table 10. Global Nausea Medicine Price by Type (2021-2026) & (US$/Unit) Table 11. Global Nausea Medicine Sales by Type (2027-2032) & (K Units) Table 12. Global Nausea Medicine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Nausea Medicine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Nausea Medicine Sales Market Share in Value by Type (2027-2032) Table 15. Global Nausea Medicine Price by Type (2027-2032) & (US$/Unit) Table 16. North America Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 17. North America Nausea Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 19. Europe Nausea Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Nausea Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 23. Latin America Nausea Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Nausea Medicine Sales by Type (2021-2026) & (US$ Million) Table 26. Nausea Medicine Industry Trends Table 27. Nausea Medicine Industry Drivers Table 28. Nausea Medicine Industry Opportunities and Challenges Table 29. Nausea Medicine Industry Restraints Table 30. Global Nausea Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Nausea Medicine Revenue Market Share by Company (2021-2026) Table 32. Global Nausea Medicine Sales by Company (2021-2026) & (K Units) Table 33. Global Nausea Medicine Sales Share by Company (2021-2026) Table 34. Global Nausea Medicine Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Nausea Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Nausea Medicine Major Company Production Sites and Headquarters Table 37. Global Nausea Medicine Company, Product Type & Application Table 38. Global Nausea Medicine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Nausea Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Nausea Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Nausea Medicine Sales by Region (2021-2026) & (K Units) Table 43. Global Nausea Medicine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Nausea Medicine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Nausea Medicine Sales Market Share in Value by Region (2021-2026) Table 46. Global Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Nausea Medicine Sales by Region (2027-2032) & (K Units) Table 48. Global Nausea Medicine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Nausea Medicine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Nausea Medicine Sales Market Share in Value by Region (2027-2032) Table 51. Global Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Nausea Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 54. Global Nausea Medicine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Nausea Medicine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Nausea Medicine Sales Market Share in Value by Application (2021-2026) Table 57. Global Nausea Medicine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Nausea Medicine Sales by Application (2027-2032) & (K Units) Table 59. Global Nausea Medicine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Nausea Medicine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Nausea Medicine Sales Market Share in Value by Application (2027-2032) Table 62. Global Nausea Medicine Price by Application (2027-2032) & (US$/Unit) Table 63. North America Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 64. North America Nausea Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 66. Europe Nausea Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Nausea Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 70. Latin America Nausea Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Nausea Medicine Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sanofi Nausea Medicine Product Portfolio Table 77. Sanofi Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck Nausea Medicine Product Portfolio Table 82. Merck Recent Development Table 83. Roche Company Information Table 84. Roche Business Overview Table 85. Roche Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Roche Nausea Medicine Product Portfolio Table 87. Roche Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pfizer Nausea Medicine Product Portfolio Table 92. Pfizer Recent Development Table 93. GlaxoSmithKline Company Information Table 94. GlaxoSmithKline Business Overview Table 95. GlaxoSmithKline Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline Nausea Medicine Product Portfolio Table 97. GlaxoSmithKline Recent Development Table 98. TESARO Company Information Table 99. TESARO Business Overview Table 100. TESARO Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. TESARO Nausea Medicine Product Portfolio Table 102. TESARO Recent Development Table 103. ANI Pharmaceuticals Company Information Table 104. ANI Pharmaceuticals Business Overview Table 105. ANI Pharmaceuticals Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. ANI Pharmaceuticals Nausea Medicine Product Portfolio Table 107. ANI Pharmaceuticals Recent Development Table 108. North America Nausea Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. North America Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 110. North America Nausea Medicine Sales Market Share by Country (2021-2026) Table 111. North America Nausea Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 112. North America Nausea Medicine Sales Market Share Forecast by Country (2027-2032) Table 113. North America Nausea Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Nausea Medicine Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Nausea Medicine Market Share by Country (2021-2026) Table 116. North America Nausea Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Nausea Medicine Market Share Forecast by Country (2027-2032) Table 118. Europe Nausea Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Europe Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 120. Europe Nausea Medicine Sales Market Share by Country (2021-2026) Table 121. Europe Nausea Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 122. Europe Nausea Medicine Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Nausea Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Nausea Medicine Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Nausea Medicine Market Share by Country (2021-2026) Table 126. Europe Nausea Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Nausea Medicine Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Nausea Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 130. Asia-Pacific Nausea Medicine Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Nausea Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 132. Asia-Pacific Nausea Medicine Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Nausea Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Nausea Medicine Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Nausea Medicine Market Share by Country (2021-2026) Table 136. Asia-Pacific Nausea Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Nausea Medicine Market Share Forecast by Country (2027-2032) Table 138. Latin America Nausea Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Latin America Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 140. Latin America Nausea Medicine Sales Market Share by Country (2021-2026) Table 141. Latin America Nausea Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 142. Latin America Nausea Medicine Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Nausea Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Nausea Medicine Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Nausea Medicine Market Share by Country (2021-2026) Table 146. Latin America Nausea Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Nausea Medicine Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Nausea Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 150. Middle East and Africa Nausea Medicine Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Nausea Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 152. Middle East and Africa Nausea Medicine Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Nausea Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Nausea Medicine Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Nausea Medicine Market Share by Country (2021-2026) Table 156. Middle East and Africa Nausea Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Nausea Medicine Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Nausea Medicine Distributors List Table 161. Nausea Medicine Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Nausea Medicine Image Figure 2. Global Nausea Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nausea Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Nausea Medicine Sales (2021-2032) & (K Units) Figure 5. Antagonists Image Figure 6. Global Antagonists Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antacids Image Figure 8. Global Antacids Sales YoY Growth (2021-2032) & (K Units) Figure 9. Steroids Image Figure 10. Global Steroids Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Nausea Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Nausea Medicine Market Share by Type 2025 VS 2032 Figure 15. North America Nausea Medicine Sales Market Share in Volume by Type in 2025 Figure 16. North America Nausea Medicine Sales Market Share in Value by Type in 2025 Figure 17. Europe Nausea Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Nausea Medicine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Nausea Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Nausea Medicine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Nausea Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Nausea Medicine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Nausea Medicine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Nausea Medicine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Nausea Medicine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pharmaceutical Companies Image Figure 28. Global Pharmaceutical Companies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Nausea Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Nausea Medicine Market Share by Application 2025 VS 2032 Figure 35. North America Nausea Medicine Sales Market Share in Volume by Application in 2025 Figure 36. North America Nausea Medicine Sales Market Share in Value by Application in 2025 Figure 37. Europe Nausea Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Nausea Medicine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Nausea Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Nausea Medicine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Nausea Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Nausea Medicine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Nausea Medicine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Nausea Medicine Sales Market Share in Value by Application in 2025 Figure 45. North America Nausea Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Nausea Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Nausea Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Nausea Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nausea Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Nausea Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nausea Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Nausea Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nausea Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Nausea Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Nausea Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Nausea Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nausea Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Nausea Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Nausea Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Nausea Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nausea Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Nausea Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Nausea Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Nausea Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Nausea Medicine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Nausea Medicine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Antagonists
  • Antacids
  • Steroids
  • Others
Applications
  • Pharmaceutical Companies
  • Clinics
  • Hospital
Companies covered
  • Sanofi
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • TESARO
  • ANI Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nausea Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nausea Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nausea Medicine Market by Type
  6. 1.3.1 Antagonists
  7. 1.3.2 Antacids
  8. 1.3.3 Steroids
  9. 1.3.4 Others
  10. 1.4 Global Nausea Medicine Market Size by Type
  11. 1.4.1 Global Nausea Medicine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Nausea Medicine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Nausea Medicine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Nausea Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Nausea Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Nausea Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Nausea Medicine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Nausea Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nausea Medicine Industry Trends
  2. 2.2 Nausea Medicine Industry Drivers
  3. 2.3 Nausea Medicine Industry Opportunities and Challenges
  4. 2.4 Nausea Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nausea Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Nausea Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Nausea Medicine Price (2021-2026)
  4. 3.4 Global Nausea Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nausea Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Nausea Medicine Company, Product Type & Application
  7. 3.7 Global Nausea Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nausea Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nausea Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nausea Medicine Tier 1, Tier 2, and Tier 3
4 Nausea Medicine Regional Status and Outlook
  1. 4.1 Global Nausea Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nausea Medicine Historic Market Size by Region
  3. 4.2.1 Global Nausea Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nausea Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nausea Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nausea Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Nausea Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nausea Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nausea Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nausea Medicine by Application
  1. 5.1 Nausea Medicine Market by Application
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Clinics
  4. 5.1.3 Hospital
  5. 5.2 Global Nausea Medicine Market Size by Application
  6. 5.2.1 Global Nausea Medicine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nausea Medicine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nausea Medicine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nausea Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nausea Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nausea Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nausea Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nausea Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Nausea Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Nausea Medicine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Nausea Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Nausea Medicine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Nausea Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Nausea Medicine Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Nausea Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Nausea Medicine Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Nausea Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Nausea Medicine Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 TESARO
  32. 6.6.1 TESARO Company Information
  33. 6.6.2 TESARO Business Overview
  34. 6.6.3 TESARO Nausea Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 TESARO Nausea Medicine Product Portfolio
  36. 6.6.5 TESARO Recent Developments
  37. 6.7 ANI Pharmaceuticals
  38. 6.7.1 ANI Pharmaceuticals Company Information
  39. 6.7.2 ANI Pharmaceuticals Business Overview
  40. 6.7.3 ANI Pharmaceuticals Nausea Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ANI Pharmaceuticals Nausea Medicine Product Portfolio
  42. 6.7.5 ANI Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Nausea Medicine Sales by Country
  2. 7.1.1 North America Nausea Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nausea Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Nausea Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nausea Medicine Market Size by Country
  6. 7.2.1 North America Nausea Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nausea Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Nausea Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nausea Medicine Sales by Country
  2. 8.1.1 Europe Nausea Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nausea Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Nausea Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nausea Medicine Market Size by Country
  6. 8.2.1 Europe Nausea Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nausea Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nausea Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nausea Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Nausea Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nausea Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nausea Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nausea Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Nausea Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nausea Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nausea Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nausea Medicine Sales by Country
  2. 10.1.1 South America Nausea Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nausea Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Nausea Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nausea Medicine Market Size by Country
  6. 10.2.1 South America Nausea Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nausea Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Nausea Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nausea Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Nausea Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nausea Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nausea Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nausea Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Nausea Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nausea Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nausea Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nausea Medicine Value Chain Analysis
  2. 12.1.1 Nausea Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nausea Medicine Production Mode & Process
  7. 12.2 Nausea Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nausea Medicine Distributors
  10. 12.2.3 Nausea Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst